Indian subjects in clinical trials are vulnerable lot

Rama Kant Mishra 4 years ago Region: India

The government of India enacted a new rule that allows foreign pharmaceutical companies and other interested parties to conduct trials of new drugs in India during the same time that trials of the same phase are being cond... more

Views: 2375